Image
Dr. Kalbasi is a physician-scientist at Stanford University. In the clinic, he specializes in the treatment of patients with solid tumors, especially sarcoma and melanoma. Dr. Kalbasi's NIH-funded laboratory studies the cancer-immune interface in emerging therapeutic contexts, including T cell therapy, cytokine therapy and innate immune agonism. Dr. Kalbasi is also an experienced leader of clinical trials related to immunotherapy, T cell therapy and radiation therapy.
Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.